Cargando…
Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation
The androgen receptor (AR) is a ligand activated transcription factor and member of the steroid hormone receptor (SHR) subfamily of nuclear receptors. In the early stages of prostate carcinogenesis, tumour growth is dependent on androgens, and AR directly mediates these effects by modulating gene ex...
Autores principales: | Lavery, Derek N., Bevan, Charlotte L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022265/ https://www.ncbi.nlm.nih.gov/pubmed/21274273 http://dx.doi.org/10.1155/2011/862125 |
Ejemplares similares
-
Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
por: Dart, D. A., et al.
Publicado: (2011) -
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer
por: Leach, Damien A, et al.
Publicado: (2022) -
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021) -
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
por: Estébanez-Perpiñá, Eva, et al.
Publicado: (2021) -
Engineered repressors are potent inhibitors of androgen receptor activity
por: Brooke, Greg N., et al.
Publicado: (2014)